Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...
This report describes and explains the liquid biopsy for cancer diagnostics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...
UBS analyst Matthew Weston maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF338.00. The ...
Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...
The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview of the global cardiac biomarkers ...